Pfizer and Moderna forecast $26 billion and $19.2 billion in annual sales of their vaccines, respectively
J&J raised its expectations for full-year sales to a range of $93.8 billion to $94.6 billion including contribution from the single-dose vaccine, and to $91.3 billion-$92.1 billion for the rest of the business
Pfizer is now planning to test its vaccine on children aged between five to 11, while China has approved Sinovac Biotech's shot for emergency use in children as young as three
Italy on May 31 approved extending the use of Pfizer's vaccine to 12-15 year olds.
The European Medicines Agency's endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany's BioNTech, to include 12- to 15-year-olds. It is already being used in the European Union for those aged 16 and older.
Inoculating children and young people is considered a critical step toward reaching "herd immunity" and taming the pandemic.
Maria Jesus Montero said the total was equivalent to twice the target population in Spain, where around 8.1 million people have already received a full course of vaccines.
"Pfizer and BioNTech are pledging to provide 2 billion doses of our COVID-19 vaccines to middle- and low-income countries over the next 18 months," Albert Bourla told a global health summit.
Biden will export vaccines from Pfizer Inc Moderna Inc or Johnson & Johnson, on top of 60 million doses from AstraZeneca Plc's vaccine he had already planned to give to other countries, Bloomberg said.
It has been trying to speed up the rollout of jabs after it was stalled by supply hold-ups in Europe and concerns about blood clots tied to the AstraZeneca shot.
The deal also includes the supply of 15 million doses of Moderna's updated variant booster vaccine candidate to be delivered in 2022, the company said.
The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.
"The government has acquired COVID-19 vaccines large enough to vaccinate approximately 100 million people...(which) is double the entire population of South Korea," Health Minister Kwon Deok-cheol told a briefing.
Britain is prioritising giving first doses of COVID-19 vaccine, allowing up to 12 weeks before a second dose, to give the maximum number of people some initial protection.
* It therefore urged the CMO to "urgently review the UK's current position of second doses after 12 weeks".